Derek J Maetzold Castle Biosciences Inc (CSTL) insider trading activity

Derek J Maetzold is Pres. & Chief Exec. Officer of CASTLE BIOSCIENCES INC. Currently has a direct ownership of 57,893 shares of CSTL, which is worth approximately $1.26 Million. The most recent transaction as insider was on Jun 03, 2024, when has been sold 2,368 shares (Common Stock) at a price of $23.68 per share, resulting in proceeds of $56,074. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.9K

16.98% 3M change

61.19% 12M change

Total Value Held $1.26 Million

DEREK J MAETZOLD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2024	SELL Open market or private sale	$56,074 $23.68 p/Share	2,368 Reduced 3.93%	57,893 Common Stock
May 14 2024	SELL Open market or private sale	$58,158 $24.56 p/Share	2,368 Reduced 3.78%	60,261 Common Stock
May 06 2024	SELL Open market or private sale	$58,536 $24.72 p/Share	2,368 Reduced 3.64%	62,629 Common Stock
Apr 23 2024	SELL Open market or private sale	$8,466 $20.11 p/Share	421 Reduced 0.64%	64,997 Common Stock
Apr 12 2024	SELL Open market or private sale	$39,621 $20.35 p/Share	1,947 Reduced 2.89%	65,418 Common Stock
Apr 03 2024	SELL Open market or private sale	$51,385 $21.7 p/Share	2,368 Reduced 3.4%	67,365 Common Stock
Mar 21 2024	SELL Open market or private sale	$1,511 $20.7 p/Share	73 Reduced 0.1%	69,733 Common Stock

Mar 20 2024	SELL Open market or private sale	$46,519 $20.27 p/Share	2,295 Reduced 3.18%	69,806 Common Stock
Mar 07 2024	SELL Open market or private sale	$49,266 $20.77 p/Share	2,372 Reduced 3.19%	72,101 Common Stock
Mar 05 2024	SELL Open market or private sale	$88,444 $21.41 p/Share	4,131 Reduced 5.26%	74,473 Common Stock
Mar 05 2024	BUY Exercise of conversion of derivative security	$39,751 $3.72 p/Share	10,686 Added 11.97%	78,604 Common Stock
Dec 28 2023	SELL Open market or private sale	$87,660 $22.17 p/Share	3,954 Reduced 5.81%	64,084 Common Stock
Dec 27 2023	SELL Open market or private sale	$176,864 $21.9 p/Share	8,076 Reduced 10.61%	68,038 Common Stock
Dec 26 2023	SELL Open market or private sale	$113,597 $21.93 p/Share	5,180 Reduced 6.37%	76,114 Common Stock
Dec 22 2023	SELL Open market or private sale	$114,719 $21.96 p/Share	5,224 Reduced 6.04%	81,294 Common Stock
Dec 21 2023	SELL Open market or private sale	$235,378 $21.4 p/Share	10,999 Reduced 11.28%	86,518 Common Stock
Dec 20 2023	SELL Open market or private sale	$109,481 $21.05 p/Share	5,201 Reduced 5.06%	97,517 Common Stock
Dec 19 2023	SELL Open market or private sale	$119,183 $20.84 p/Share	5,719 Reduced 5.27%	102,718 Common Stock
Dec 18 2023	SELL Open market or private sale	$115,944 $20.27 p/Share	5,720 Reduced 5.01%	108,437 Common Stock
Dec 15 2023	SELL Open market or private sale	$74,958 $20.21 p/Share	3,709 Reduced 3.15%	114,157 Common Stock
Dec 14 2023	SELL Open market or private sale	$194,754 $21.28 p/Share	9,152 Reduced 7.21%	117,866 Common Stock
Dec 13 2023	SELL Open market or private sale	$73,806 $20.21 p/Share	3,652 Reduced 2.79%	127,018 Common Stock
Dec 12 2023	SELL Open market or private sale	$10,925 $20.01 p/Share	546 Reduced 0.42%	130,670 Common Stock
Dec 10 2023	SELL Payment of exercise price or tax liability	$130,721 $20.17 p/Share	6,481 Reduced 4.71%	131,216 Common Stock
Dec 10 2023	BUY Exercise of conversion of derivative security	-	20,787 Added 13.49%	133,327 Common Stock

DJM

Derek J Maetzold

Pres. & Chief Exec. Officer

Friendswood, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSTL shares.

Notify only if

Value

Insider Trading

Get notified when an Castle Biosciences Inc insider buys or sells CSTL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CASTLE BIOSCIENCES INC

Track Activities on CSTL

Account